0.4087

6.24% -0.0272

After Hours: .42 0.0113 +2.76%

Generation Bio Co (GBIO)

Overview News Price History Option Chain Financials Why GBIO Down? Discussions Forecast

Generation Bio Co stock is traded at $0.4087, with a volume of 260.80K. It is down -6.24% in the last 24 hours and up +9.72% over the past month. Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Previous Close:

$0.4359

Open:

$0.42

24h Volume:

260.80K

Relative Volume:

0.57

Market Cap:

$28.91M

Revenue:

Net Income/Loss:

$-126.61M

P/E Ratio:

-0.2085

EPS:

-1.96

Net Cash Flow:

$-60.14M

1W Performance:

-5.26%

1M Performance:

+9.72%

6M Performance:

-81.34%

1Y Performance:

-87.11%

1-Day Range:

$0.4002

$0.449

1-Week Range:

$0.4001

$0.454

52-Week Range:

$0.316

$4.34

Generation Bio Co Stock (GBIO) Company Profile

Name

Generation Bio Co

Sector

Healthcare (1150)

Industry

Biotechnology (676)

Phone

857-529-5908

Address

301 BINNEY STREET, CAMBRIDGE

Employee

115

Twitter

@generationbio

Next Earnings Date

2025-03-12

Latest SEC Filings

GBIO's Discussions on Twitter

Compare GBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GBIO Generation Bio Co	0.4087	28.91M	0	-126.61M	-60.14M	-1.96
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Generation Bio Co Stock (GBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-19-23	Downgrade	TD Cowen	Outperform → Market Perform
Nov-08-22	Initiated	Canaccord Genuity	Buy
Dec-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Jun-08-21	Initiated	JMP Securities	Mkt Outperform
Feb-24-21	Initiated	William Blair	Outperform
Feb-18-21	Initiated	Needham	Buy
Jul-07-20	Initiated	Cowen	Outperform
Jul-07-20	Initiated	JP Morgan	Overweight
Jul-07-20	Initiated	Jefferies	Buy
Jul-07-20	Initiated	Wedbush	Outperform

View All

Generation Bio Co Stock (GBIO) Latest News

May 05, 2025

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - ADVFN

May 05, 2025

May 02, 2025

Layoff Tracker: BMS Closes Manufacturing Plant, Arvinas Axes One-Third of Staff - BioSpace

May 02, 2025

May 01, 2025

Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

May 01, 2025

Apr 24, 2025